Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSEPH ROSENTHAL

Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology

NPI
1164526448
CMS profile
7221
Location
DUARTE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$12,155.64

3 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $12,155.64 3

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $12,155.64 3

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSEPH ROSENTHAL

NPI 1164526448 · CMS profile ID 7221

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Hematology-Oncology

DUARTE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164526448?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSEPH ROSENTHAL, NPI 1164526448, CMS profile ID 7221. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164526448?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JOSEPH ROSENTHAL, NPI 1164526448, CMS profile ID 7221. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164526448?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JOSEPH ROSENTHAL, NPI 1164526448, CMS profile ID 7221, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1164526448?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

3 matching records · $12,155.64 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 3 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–3 of 3.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $2,163.3412/17/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111692502 CMS
Amgen Inc. $8,242.3006/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111692500 CMS
Amgen Inc. $1,750.0003/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117369289 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $12,212.89 14
PY2020 $10,262.62 12
PY2021 $1,065.21 4
PY2023 $3,530.00 3
PY2024 $12,155.64 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $5,838.20 4
PY2024 Principal investigator $9,769.60 4
PY2023 Principal investigator $6,516.90 2
PY2022 Principal investigator $140,731.00 14
PY2021 Principal investigator $255,530.63 19
PY2020 Principal investigator $451,514.20 30
PY2019 Principal investigator $101,420.14 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Kite Pharma, Inc. $3,200.00 12/12/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA 4) No dispute reported 06/30/2026 665970129
Principal investigator 1 CSL Behring $1,000.00 11/21/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease No dispute reported 06/30/2026 676681749
Principal investigator 1 CSL Behring $2,500.00 11/21/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease No dispute reported 06/30/2026 676681751
Principal investigator 1 CSL Behring $5,000.00 11/21/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease No dispute reported 06/30/2026 676681753
Principal investigator 1 CSL Behring $6,500.00 11/21/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease No dispute reported 06/30/2026 676681755
Principal investigator 1 CSL Behring $5,000.00 11/21/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease No dispute reported 06/30/2026 676681757
Principal investigator 1 CSL Behring $90.00 11/21/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Phase 1 Pilot Study to Evaluate the Safety and Feasibility of Gene Therapy With CSL200 (Autologous Enriched CD34+ Cell Fraction That Contains CD34+ Cells Transduced With Lentiviral Vector Encoding Human -GlobinG16D and Short-Hairpin RNA734) in Adult Subjects With Severe Sickle Cell Disease No dispute reported 06/30/2026 764405468
Principal investigator 1 CSL Behring $162.00 10/14/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Phase 1 Pilot Study to Evaluate the Safety and Feasibility of Gene Therapy With CSL200 (Autologous Enriched CD34+ Cell Fraction That Contains CD34+ Cells Transduced With Lentiviral Vector Encoding Human -GlobinG16D and Short-Hairpin RNA734) in Adult Subjects With Severe Sickle Cell Disease No dispute reported 06/30/2026 764405502
Principal investigator 1 CSL Behring $457.00 10/10/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Phase 1 Pilot Study to Evaluate the Safety and Feasibility of Gene Therapy With CSL200 (Autologous Enriched CD34+ Cell Fraction That Contains CD34+ Cells Transduced With Lentiviral Vector Encoding Human -GlobinG16D and Short-Hairpin RNA734) in Adult Subjects With Severe Sickle Cell Disease No dispute reported 06/30/2026 764405584
Principal investigator 1 CSL Behring $972.00 09/09/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Phase 1 Pilot Study to Evaluate the Safety and Feasibility of Gene Therapy With CSL200 (Autologous Enriched CD34+ Cell Fraction That Contains CD34+ Cells Transduced With Lentiviral Vector Encoding Human -GlobinG16D and Short-Hairpin RNA734) in Adult Subjects With Severe Sickle Cell Disease No dispute reported 06/30/2026 764405632
Principal investigator 1 Daiichi Sankyo Inc. $642.40 05/30/2019 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
DS3032-A-U102 No dispute reported 06/30/2026 688834801
Principal investigator 1 CSL Behring $75,896.74 02/11/2019 Covered Recipient Teaching Hospital
UCI MEDICAL CENTER
A Phase 1 Pilot Study to Evaluate the Safety and Feasibility of Gene Therapy With CSL200 Autologous Enriched CD34 Cell Fraction That Contains CD34 Cells Transduced With Lentiviral Vector Encoding Human-GlobinG16D and Short-Hairpin RNA734 in Adult Subjects With Severe Sickle Cell Disease No dispute reported 06/30/2026 676689889